Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)
China flag China · Delayed Price · Currency is CNY
25.63
+0.20 (0.79%)
Apr 30, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Industry
308.64M314.25M236.32M345.00M253.64M
Pharmaceutical Industry Growth
-1.78%32.97%-31.50%36.02%44.52%
Unallocated Other Industries
30.90M34.75M33.54M28.88M29.61M
Unallocated Other Industries Growth
-11.09%3.63%16.13%-2.48%19.73%
Total
339.54M349.00M269.86M373.88M283.25M
Total Growth
-2.71%29.33%-27.82%32.00%41.46%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China
297.22M323.97M247.41M355.07M270.69M
China Growth
-8.26%30.94%-30.32%31.17%43.75%
Foreign
42.32M25.03M22.45M18.81M12.56M
Foreign Growth
69.07%11.52%19.32%49.78%5.29%
Total
339.54M349.00M269.86M373.88M283.25M
Total Growth
-2.71%29.33%-27.82%32.00%41.46%
Source: S&P Global Market Intelligence.